Actually the price was at HOD of $15.45 on about 25,000 volume early this morning and even was higher in AH last night to $15.75 I believe. It has been slowly coming down since and hit the LOD of $14.49 a few minutes ago on 145,000 volume My personal opinion is it will go back up,maybe today.But for now the games continue as I am sure Wall Street knew of Stryker partnership days ago
Sentiment: Strong Buy
SAN FRANCISCO, CA and YAVNE, ISRAEL -- (Marketwired) -- 12/22/14 -- Medivation, Inc. (NASDAQ:MDVN) today announced that it has exercised its option under the terms of the license agreement announced on October 23, 2014, for pidilizumab (CT-011), an immune modulatory anti-PD-1 monoclonal antibody from CureTech, Ltd. Under the license agreement, Medivation will be responsible for all development, regulatory and commercialization activities for pidilizumab for all indications, including oncology.
The agreement includes a guaranty with respect to certain obligations of CureTech by Clal Biotechnology Industries Ltd. (CBI), CureTech's largest (53%) shareholder. The guaranty has been approved by CBI shareholders. Under the terms of the license agreement, CureTech will receive an upfront payment of $5.0 million from Medivation and would also be entitled to payments upon the attainment of certain development and regulatory milestones totaling up to $85 million. In addition, CureTech would be eligible to receive sales-based milestone payments totaling up to $245 million upon the achievement of certain annual worldwide net sales thresholds and tiered royalties ranging from 5%-11% based on annual worldwide net sales.
Pidilizumab is a humanized monoclonal antibody which belongs to a class of anticancer therapies that target the immune system. Cancer cells evade destruction by suppressing immune T lymphocytes through activation of the PD-1 (programmed death-1) pathway. Pidilizumab binds the PD-1 protein on T lymphocytes and facilitates the T cells' ability to target and destroy cancer cells....
What they are auctioned off for and what they are worth are not necessarily the same thing and the BOD has not been acting in the best interest of long shareholders in quite some time
they would have been profitable....but that would have ruined their plan
The ? is why would they want a company they say is a POS and cannot possibly make Money. These are the same people (corporations) that have been trying and suceeding to destroy this company. I think the government is in on it and this was the plan from day 1. How else have they gotten away with their blatant manipulation of this company with no reprecussions
They don,t care they just want the Company,,,,,,,,,,,,,,Court papers say bondholders will take bids in excess of $275 million for Dendreon and are leaving the door open to offers until the end of January. If no prospective buyers step up, bondholders would swap out their debt for equity in a reorganized company in hopes of recouping some of their losses..............................what a joke
The Bond holders want Dendreon so they can get to all the patents and so on then finish destroying Dendreon completely
Why would they agree to take over a POS company that is bleeding cash and will cause them to lose more money? Answer: They wouldn't. They are not stupid,they are ruthless though. This has been the gameplan from the beginning with Dendreon as their partner (in crime).....when you look at it this way everything makes alot more sense........was the government in on it too?
The reason is management only represent the hedge funds so the goal is to get rid of all individual investors. Apparently they have more work to do. It looks like they will do anything to accomplish this goal